Pharmaceuticals: manufacturers' price-fixing schemes challenged

Journal of Law, Medicine and Ethics 25 (4):325 (1997)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,795

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Pharmaceuticals: FDA labeling time line.J. M. Levy - 1996 - Journal of Law, Medicine and Ethics 25 (1):75-76.
Pharmaceuticals: managing managed care and recent FDA responses.A. R. Ragade - 1997 - Journal of Law, Medicine and Ethics 26 (1):68-72.
Pharmacy Benefit Management: The Cost of Drug Price Rebates.James C. Robinson - 2023 - Journal of Law, Medicine and Ethics 51 (S2):52-54.
Recent Case Developments in Health Law.Sally Wang, Jeremy O. Bressman & Jay S. Reidler - 2010 - Journal of Law, Medicine and Ethics 38 (3):708-716.
Recent Case Developments in Health Law.Stacy Clark, Jessica Palmer & Dayna Fullerton - 2010 - Journal of Law, Medicine and Ethics 38 (1):160-167.
Antitrust: Ideology or economics?F. M. Scherer - 1991 - Critical Review: A Journal of Politics and Society 5 (4):497-511.
Conditions on Certificates of Need: Approval at What Price?W. Thomas Berriman - 1981 - Journal of Law, Medicine and Ethics 9 (4):4-10.

Analytics

Added to PP
2014-03-31

Downloads
6 (#1,700,713)

6 months
2 (#1,693,059)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references